Jacobs Levy Equity Management, Inc Johnson & Johnson Transaction History

Jacobs Levy Equity Management, Inc

$23.2 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	BUY	$155.75 - $174.48 $87,687 - $98,232	563 Added 14.84%	4,358 $678,000
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $13,737 - $14,783	-89 Reduced 2.29%	3,795 $628,000
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $825,186 - $984,760	-5,463 Reduced 58.45%	3,884 $602,000
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $76,735 - $86,119	-479 Reduced 4.87%	9,347 $1.65 Million
Q3 2022 Nov 15, 2022	BUY	$161.33 - $179.52 $161,330 - $179,520	1,000 Added 11.33%	9,826 $1.61 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $426,361 - $471,535	2,535 Added 40.3%	8,826 $1.57 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $309,479 - $351,457	1,957 Added 45.15%	6,291 $1.12 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $228,593 - $253,632	-1,466 Reduced 25.28%	4,334 $741,000
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $99,968 - $111,091	619 Added 11.95%	5,800 $937,000
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $387,855 - $416,042	2,432 Added 88.47%	5,181 $854,000
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $198,225 - $220,771	-1,295 Reduced 32.02%	2,749 $452,000
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $870,785 - $999,520	-6,351 Reduced 61.1%	4,044 $636,000
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $379,166 - $415,494	2,701 Added 35.11%	10,395 $1.55 Million
Q2 2020 Aug 17, 2020	SELL	$128.81 - $155.51 $622,667 - $751,735	-4,834 Reduced 38.59%	7,694 $1.08 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $438,669 - $607,798	3,947 Added 46.0%	12,528 $1.64 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $684,547 - $786,236	-5,369 Reduced 38.49%	8,581 $1.25 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $3.2 Million - $3.58 Million	-25,210 Reduced 64.38%	13,950 $1.81 Million
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $2.38 Million - $2.62 Million	18,180 Added 86.65%	39,160 $5.45 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $331,900 - $369,045	2,640 Added 14.39%	20,980 $2.93 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $1.58 Million - $1.9 Million	-12,850 Reduced 41.2%	18,340 $2.37 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $5.82 Million - $6.85 Million	-47,910 Reduced 60.57%	31,190 $4.31 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $600,582 - $662,752	-5,030 Reduced 5.98%	79,100 $9.6 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $7.94 Million - $9.4 Million	63,440 Added 306.62%	84,130 $10.8 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $34.4 Million - $37.6 Million	-261,840 Reduced 92.68%	20,690 $2.89 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $220,099 - $230,146	-1,700 Reduced 0.6%	282,530 $36.7 Million
Q2 2017 Nov 09, 2017	BUY	N/A	284,230	284,230 $37.6 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account